With the large number of clinical trials, multiple novel therapeutics in development, and improved classification and outcome measures, the treatment landscape for DM will continue to rapidly evolve in the coming years as more options become available.
Keyphrases
- clinical trial
- small molecule
- machine learning
- deep learning
- interstitial lung disease
- single cell
- disease activity
- type diabetes
- metabolic syndrome
- randomized controlled trial
- rheumatoid arthritis
- systemic lupus erythematosus
- systemic sclerosis
- insulin resistance
- idiopathic pulmonary fibrosis
- glycemic control
- study protocol
- double blind